A company for life

We're a company that is built from within: leadership from key and relevant sectors and a business ethos that is managed with integrity.

Investment opportunity

Autolomous is led by highly knowledgeable founders. They bring together decades of advanced therapy manufacturing experience and enterprise-level technical expertise. Deploying this expertise within an agile start-up environment allows Autolomous to excel in a highly complex sector.

2019

Founded

20

Employees

6

Clients globally

Turning your ideas into reality

As global demand for advanced therapy treatments increases, Autolomous will equip ATMP manufacturers with the systems they will need to future-proof their business.

2019

Founded

20

Employees

6

Clients globally

Market opportunities

Autolomous is a proven startup, led by industry experts, which has demonstrated the need for an advanced therapy specific digital platform. In only two years since our inception we have already secured international advanced therapy manufacturers as trusted clients.

Growth enabler for ATMP industry

Autolomous provides a digital platform for data management within advanced therapy manufacturing, enabling the anticipated exponential growth of manufacturing operations.

Led by industry experts

Over the past 2 years, Autolomous has leveraged our industry networks to secure an international early adopter client base as well as innovation grant & support from UKRI (UK Research and Innovation).  

Market-leading team

Autolomous' team has grown from 5 to 15 team members in 2 years, key roles now being filled by individuals from the advanced therapy industry to provide our clients reassurance and to accelerate our platform's development and adoption.

Trust, security and integrity

Autolomous is committed to managing its partnerships through trust and integrity. Our solutions ensure security and reliability both via the technology we employ and the quality & information security management system adopted internally.

Roadmap

Highlights

ISO9001 & 27001 certification on its way

Autolomous has implemented an integrated Quality and Information Security Management system and plans to achieve both ISO/IEC 9001:2015 and ISO/IEC 27001:2013 certification in Q4 this year.

Growing Advanced Therapy industry

As per the latest reports, sector financing reached $19.9B in 2020, doubling from the previous year. It is likely 2021 will be a record year for the number of regulatory decisions on new regenerative medicine products.

Consolidation of US presence

With a US client already secured, we are continuing to consolidate our presence in this market through establishing partnerships in the advanced therapy ecosystem with reputed suppliers.

Request an info pack

To delve further into what we do at Autolomous, contact us to request an info pack or to get more details.